Drugs / Lucron Depot
last change Jan 2005 re-read 2 minutes ago

Lucron Depot

Developed for
leiomyoma

Trials 0

Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1/2 NCT01069094 Comparator Jul 2004 → Jan 2005 leiomyoma Repros Therapeutics Inc. Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Lucron Depot ClinicalTrials.gov intervention name — accepted as the source's own label NCT01069094
Route Intramuscular “3.75 mg IM monthly” NCT01069094